Suzhou Accounts Payable from 2010 to 2025

688137 Stock   33.59  0.63  1.84%   
Suzhou Novoprotein's Accounts Payable is increasing over the years with slightly volatile fluctuation. Accounts Payable is expected to dwindle to about 19.4 M. Accounts Payable is the amount Suzhou Novoprotein Scientific owes to suppliers or vendors for products or services received but not yet paid for. It represents Suzhou Novoprotein's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2010-12-31
Previous Quarter
20.6 M
Current Value
19.4 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Suzhou Novoprotein financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suzhou Novoprotein's main balance sheet or income statement drivers, such as Net Interest Income of 32.4 M, Interest Income of 36.8 M or Interest Expense of 2.9 M, as well as many indicators such as . Suzhou financial statements analysis is a perfect complement when working with Suzhou Novoprotein Valuation or Volatility modules.
  
This module can also supplement various Suzhou Novoprotein Technical models . Check out the analysis of Suzhou Novoprotein Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Suzhou Stock

Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.